Cite
APA Citation
Panoutsopoulou, K., Avgeris, M., Magkou, P., Mavridis, K., Dreyer, T., Dorn, J., Obermayr, E., Reinthaller, A., Michaelidou, K., Mahner, S., Vergote, I., Loverix, L., Braicu, I., Sehouli, J., Zeillinger, R., Magdolen, V., & Scorilas, A. (2020). miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients. International journal of cancer, 147(12), 3560–3573. http://access.bl.uk/ark:/81055/vdc_100113084045.0x000060